This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frederick L. Brancati, MD, MHS; William S. Queale, MD, MS
Baltimore, Md

Arch Intern Med. 1997;157(21):2524.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Trochtenberg suggests that sliding scale insulin regimens that reach a maximum of 20 U of insulin may perform better than those that stop at 12 U. Because the physicians in our study^' generally did not prescribe such aggressive sliding scale insulin, we are unable to test this hypothesis directly. Nonetheless, we question this hypothesis for several reasons. First, there was no apparent association in our study between the type of sliding scale and the performance: aggressive scales performed as poorly as conservative scales. Second, the use of very aggressive sliding scale insulin should only increase the risk for hypoglycemia. Third, the beneficial effects of very aggressive sliding scale insulin on hyperglycemia are likely to be short-lived unless the underlying long-acting hypoglycemic regimen is modified accordingly. In light of Trochtenberg's comment that he "rarely treat[s] patients with diabetes mellitus using the sliding scale regimen alone," we suspect that the apparent success . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?